Literature DB >> 24668239

Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy.

Jung Hyun Lee1, So Hyun Park, Dae Gyun Koh, Byung Kyu Suh.   

Abstract

BACKGROUND: Graves' ophthalmopathy (GO) occurs commonly in children with Graves' disease (GD). However, there are limited studies on the clinical manifestations and thyroid autoantibodies in pediatric GO. The aim of this study was to investigate the prevalence and risk factors of GO in childhood GD.
METHODS: Clinical and biochemical data from children and adolescents with GD were retrospectively reviewed. Eighty patients under 19 years of age were included in the present study. We compared the clinical and biochemical differences between patients with and without GO.
RESULTS: Thirty-nine percent of the patients had GO, and 81% of the GO patients were females. Of these, two patients showed unilateral GO. Triiodothyronine (T3) levels were higher in GO patients than in those without GO. Anti-thyroglobulin antibody and thyroid stimulating hormone receptor antibody titers were not significantly different between the two groups. Anti-thyroid peroxidase antibody (TPO Ab) positivity was 68% in the patients with GO and only 47% in the patients without GO. In multivariate regression analysis, high T3 levels and TPO Ab positivity were related to the presence of GO.
CONCLUSION: In children and adolescents with GD, TPO Ab positivity and high T3 levels could act as predictive factors for the presence of GO.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668239     DOI: 10.1007/s12519-014-0476-y

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  24 in total

Review 1.  Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.

Authors:  Gerasimos E Krassas; Apostolos Gogakos
Journal:  J Pediatr Endocrinol Metab       Date:  2006-10       Impact factor: 1.634

2.  The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.

Authors:  D H Khoo; S C Ho; L L Seah; K S Fong; E S Tai; S P Chee; P H Eng; S E Aw; A C Fok
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

Review 3.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

4.  Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.

Authors:  Keiko Shibayama; Yoshihide Ohyama; Yukifumi Yokota; Shigeyuki Ohtsu; Noriyuki Takubo; Nobuo Matsuura
Journal:  Endocr J       Date:  2005-10       Impact factor: 2.349

5.  Limited usefulness of antithyroperoxidase and antithyroglobulin assays in Jamaicans with Graves' disease.

Authors:  R Wright-Pascoe; M F Smikle; E N Barton; O B James
Journal:  Hum Antibodies       Date:  1999

Review 6.  Bioassays for TSH-receptor autoantibodies: an update.

Authors:  Simon D Lytton; George J Kahaly
Journal:  Autoimmun Rev       Date:  2010-08-31       Impact factor: 9.754

7.  Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.

Authors:  L Bartalena; C Marcocci; F Bogazzi; L Manetti; M L Tanda; E Dell'Unto; G Bruno-Bossio; M Nardi; M P Bartolomei; A Lepri; G Rossi; E Martino; A Pinchera
Journal:  N Engl J Med       Date:  1998-01-08       Impact factor: 91.245

8.  Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.

Authors:  S M McLachlan; R Bahn; B Rapoport
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

9.  Intermethod variability in TSH-receptor antibody measurement: implication for the diagnosis of Graves disease and for the follow-up of Graves ophthalmopathy.

Authors:  Catherine Massart; Rémy Sapin; Jacqueline Gibassier; Arnaud Agin; Michèle d'Herbomez
Journal:  Clin Chem       Date:  2008-11-21       Impact factor: 8.327

10.  Graves' ophthalmopathy in childhood and adolescence.

Authors:  S H Uretsky; J S Kennerdell; J P Gutai
Journal:  Arch Ophthalmol       Date:  1980-11
View more
  7 in total

Review 1.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

2.  Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy.

Authors:  Berna Evranos Ogmen; Nagihan Ugurlu; Muhammet Cuneyt Bilginer; Sefika Burcak Polat; Birgul Genc; Reyhan Ersoy; Bekir Cakir
Journal:  Int Ophthalmol       Date:  2022-05-12       Impact factor: 2.029

3.  Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy.

Authors:  Aleksander Kuś; Konrad Szymański; Beata Jurecka-Lubieniecka; Edyta Pawlak-Adamska; Dorota Kula; Piotr Miśkiewicz; Marek Bolanowski; Rafał Płoski; Artur Bossowski; Jacek Daroszewski; Barbara Jarząb; Tomasz Bednarczuk
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

4.  Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.

Authors:  Dalia Jarusaitiene; Rasa Verkauskiene; Vytautas Jasinskas; Jurate Jankauskiene
Journal:  Int J Endocrinol       Date:  2016-06-16       Impact factor: 3.257

Review 5.  Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.

Authors:  Natacha Turck; Simone Eperon; Maria De Los Angeles Gracia; Aurélie Obéric; Mehrad Hamédani
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

6.  Risk factors for Graves' Orbitopathy in surgical patients-Results of a 10-year retrospective study with review of the literature.

Authors:  Navid Tabriz; Arved Gruben; Verena Uslar; Dirk Weyhe
Journal:  Endocrinol Diabetes Metab       Date:  2020-12-04

7.  Comparison of the ocular surface microbiota between thyroid-associated ophthalmopathy patients and healthy subjects.

Authors:  Xuan Ji; Kui Dong; Ji Pu; Jing Yang; Zhaoxia Zhang; Xiaoling Ning; Qin Ma; Zhiming Kang; Jianguo Xu; Bin Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-07-26       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.